MBX Biosciences, Inc. (MBX)
63.89
+2.32
(+3.77%)
USD |
NASDAQ |
Sep 17, 16:00
63.85
-0.04
(-0.06%)
After-Hours: 20:00
MBX Biosciences Market Cap : 3.064B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.064B |
| September 16, 2026 | 2.952B |
| September 15, 2026 | 2.929B |
| September 14, 2026 | 2.853B |
| September 11, 2026 | 2.830B |
| September 10, 2026 | 2.922B |
| September 09, 2026 | 3.017B |
| September 08, 2026 | 3.020B |
| September 04, 2026 | 2.959B |
| September 03, 2026 | 2.945B |
| September 02, 2026 | 2.920B |
| September 01, 2026 | 2.922B |
| August 31, 2026 | 2.954B |
| August 28, 2026 | 3.021B |
| August 27, 2026 | 3.183B |
| August 26, 2026 | 3.201B |
| August 25, 2026 | 3.290B |
| August 24, 2026 | 3.183B |
| August 21, 2026 | 3.181B |
| August 20, 2026 | 3.181B |
| August 19, 2026 | 3.280B |
| August 18, 2026 | 3.190B |
| August 17, 2026 | 3.273B |
| August 14, 2026 | 3.288B |
| August 13, 2026 | 3.216B |
| Date | Value |
|---|---|
| August 12, 2026 | 3.211B |
| August 11, 2026 | 3.165B |
| August 10, 2026 | 3.172B |
| August 07, 2026 | 3.252B |
| August 06, 2026 | 3.218B |
| August 05, 2026 | 3.236B |
| August 04, 2026 | 3.390B |
| August 03, 2026 | 3.064B |
| July 31, 2026 | 3.136B |
| July 30, 2026 | 3.162B |
| July 29, 2026 | 3.043B |
| July 28, 2026 | 2.857B |
| July 27, 2026 | 2.916B |
| July 24, 2026 | 2.949B |
| July 23, 2026 | 3.024B |
| July 22, 2026 | 2.773B |
| July 21, 2026 | 2.868B |
| July 20, 2026 | 2.861B |
| July 17, 2026 | 2.993B |
| July 16, 2026 | 2.774B |
| July 15, 2026 | 2.886B |
| July 14, 2026 | 2.692B |
| July 13, 2026 | 2.856B |
| July 10, 2026 | 2.904B |
| July 09, 2026 | 3.126B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amylyx Pharmaceuticals, Inc. | 3.780B |
| ANI Pharmaceuticals, Inc. | 1.732B |
| Corcept Therapeutics, Inc. | 12.40B |
| Veru, Inc. | 40.75M |
| Johnson & Johnson | 650.75B |
Market Cap Related Metrics
| PEG Ratio | -6.042 |
| Price to Book Value | 7.480 |
| Price | 63.89 |
| Earnings Yield | -3.77% |
| PEGY Ratio | -6.042 |